Cutler Group’s NanoViricides NNVC Stock Holding History

Cutler Group’s Portfolio NNVC Stock Details NNVC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-3,100	Closed	-$1K	–	5790
2021 Q4	$1K	Sell	3,100 -16,000	-84%	-$72.9K	﹤0.01%	5072
2021 Q3	$9K	Buy	+19,100	New	+$79.6K	﹤0.01%	4027

Other funds holding NNVC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Compagnie Lombard Odier SCmA 1204 Geneva, Switzerland $9.25B AUM 27.04% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Cutler Group's NNVC Position: Q3 2022 in Review

Cutler Group sold out of NanoViricides (NNVC) in Q3 2022, closing a stake of 1,100 shares — an estimated $2K sold.

Cutler Group first reported a position in NNVC in Q3 2020 and held it in 5 quarters. The position peaked at $15K in Q3 2021. 31 funds tracked by Wall St. Rank hold NNVC as of Q3 2022.

Cutler Group reported no remaining NanoViricides position as of Q3 2022 after selling out during the quarter.
Cutler Group sold 1,100 NanoViricides shares in Q3 2022, an estimated $2K.
Cutler Group first reported a position in NanoViricides in Q3 2020 and held it in 5 quarters.
Cutler Group's NanoViricides position peaked at $15K in Q3 2021.
31 funds tracked by Wall St. Rank held NanoViricides as of Q3 2022.

Based on Cutler Group's 13F filing for Q3 2022, filed 25 Oct 2022.